Update in MGUS, SMM and AL Amyloidosis, Part 2: Monoclonal Gammopathy and Amyloidosis


Related Videos (117)

In this, the second part of a two­ part series, Brendan Weiss, MD, offers an interrogative on the diagnosis and treatment of AL amyloidosis, a disorder associated with plasma cell dyscrasia. Dr. Weiss considers  the current potential for early diagnosis of the disease, and the potential for highly active anti­plasma cell chemotherapy regimens (and other therapies) to improve outcomes in advanced cardiac amyloidosis.


Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®